4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001193125-25-223665
Chief Operating Officer sold 6,892 shares at $8.94 ($61,630)
- Chief Operating Officer acquired 48,900 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
FORD KATHLEEN · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-27 | Grant or award : show line 1 in the form 10b5-1 | −48,900 | 70,267 | D | ||
| 2025-09-29 | Sale : show line 2 in the form 10b5-1 | −6,892 | $8.94 | $61,630 | 63,375 | D |
| Open-market sales · 6,892 sh · avg $8.94 · $61,630 | ||||||
Loading xslF345X05/ownership.xml…